Irritation Patch Test Study on 6AM Glow multiple products
- Registration Number
- CTRI/2023/01/049118
- Lead Sponsor
- AM Glow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.18 and 65 years of age
2.Subject should be free from any skin disease.
3.Healthy participants will be screened and enrolled for the study.
4.Subjects willing to give written informed consent.
5.Subjects able to comply with the study protocol.
6.Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
7.No restrictions on gender ethnicity will be implemented.
1.Being Diabetic
2.Subject having cutaneous Hypersentivity.
3.The day of patch application: no cosmetic product must be used(test site clean with water only)
4.Subject having highly probable allergy.
5.Following a chronic medicinal treatment comprising any of the following products: aspirin- based products, anti-inflammatory, anti-histamines, corticotherapy taken by general or local routes(the only medication permitted is paracetamol)
6.Taking part in another study liable to interfere with this study.
7.Diagnosis of any known chronic or acute medical disease.
8.Any form of prescription medication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Skin Irritation Score-erythema and oedemaTimepoint: Day 1, Day2, Day 8
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable